Literature DB >> 16786410

A non-linear mixed effect dynamic model incorporating prior exposure and adherence to treatment to describe long-term therapy outcome in HIV-patients.

Line Labbé1, Davide Verotta.   

Abstract

Long term therapy with antiretroviral agents in HIV-infected patients often result in failure to suppress the virus load. Imperfect adherence to prescribed antiviral drugs is an important factor explaining the resurgence of virus. A better understanding of the factors responsible for the virological failure is important for the development of new treatment strategies. Many complex non-linear models have been developed to describe and simulate the dynamics of HIV-1 virus. Those complicated viral dynamic models have not been used in clinical trials to estimate HIV dynamics parameters, due to their complexity, until the recent development of simplification and approximation techniques. The estimation of the parameters associated with the dynamics from real data has been mostly limited to linearized models that can only explain the decay (suppression) of the virus following antiviral treatment. Moreover, no complete characterization of typical clinical data in terms of inter-subject variability and identification of important covariates effecting HIV-1 dynamics has been attempted. The objective of our paper was to develop a hierarchical non-linear mixed effect model characterizing inter-subject variability in the long-term response to treatment of HIV-1 RNA, and show how the model can be used to quantify the effect of important covariates, such as physiological variables, adherence to treatment or previous exposure to treatment, on the dynamics of HIV-1 RNA. As an example we report the analysis of AIDS clinical trial data from AACTG 398, which shows that patients with previous exposure to treatment show faster death rates for HIV-1, and that higher adherence to treatment is associated with lower reproductive ratio.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16786410     DOI: 10.1007/s10928-006-9022-4

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  34 in total

1.  Population dynamics of immune responses to persistent viruses.

Authors:  M A Nowak; C R Bangham
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

2.  HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.

Authors:  A S Perelson; A U Neumann; M Markowitz; J M Leonard; D D Ho
Journal:  Science       Date:  1996-03-15       Impact factor: 47.728

3.  Modeling plasma virus concentration during primary HIV infection.

Authors:  M A Stafford; L Corey; Y Cao; E S Daar; D D Ho; A S Perelson
Journal:  J Theor Biol       Date:  2000-04-07       Impact factor: 2.691

4.  Human immunodeficiency virus drug therapy and virus load.

Authors:  S Bonhoeffer; J M Coffin; M A Nowak
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI.

Authors:  T W Chun; K Chadwick; J Margolick; R F Siliciano
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens.

Authors:  J Urquhart; E De Klerk
Journal:  Stat Med       Date:  1998-02-15       Impact factor: 2.373

7.  Percentage of adherence correlates with the risk of protease inhibitor (PI) treatment failure in HIV-infected patients.

Authors:  J L Casado; R Sabido; M J Perez-Elías; A Antela; J Oliva; F Dronda; B Mejía; J Fortún
Journal:  Antivir Ther       Date:  1999

8.  Mathematical analysis of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads.

Authors:  L M Wein; R M D'Amato; A S Perelson
Journal:  J Theor Biol       Date:  1998-05-07       Impact factor: 2.691

9.  Modeling HIV infection of CD4+ T-cell subpopulations.

Authors:  P Essunger; A S Perelson
Journal:  J Theor Biol       Date:  1994-10-21       Impact factor: 2.691

10.  Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.

Authors:  L J Eldred; A W Wu; R E Chaisson; R D Moore
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-06-01
View more
  9 in total

Review 1.  Modeling and simulation of adherence: approaches and applications in therapeutics.

Authors:  Leslie A Kenna; Line Labbé; Jeffrey S Barrett; Marc Pfister
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

2.  Basic PK/PD principles of drug effects in circular/proliferative systems for disease modelling.

Authors:  Philippe Jacqmin; Lynn McFadyen; Janet R Wade
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-03-04       Impact factor: 2.745

3.  A DYNAMIC BAYESIAN NONLINEAR MIXED-EFFECTS MODEL OF HIV RESPONSE INCORPORATING MEDICATION ADHERENCE, DRUG RESISTANCE AND COVARIATES().

Authors:  Yangxin Huang; Hulin Wu; Jeanne Holden-Wiltse; Edward P Acosta
Journal:  Ann Appl Stat       Date:  2011       Impact factor: 2.083

4.  A Bayesian Approach in Differential Equation Dynamic Models Incorporating Clinical Factors and Covariates.

Authors:  Yangxin Huang
Journal:  J Appl Stat       Date:  2010-02-01       Impact factor: 1.404

5.  Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients.

Authors:  Daniel Röshammar; Ulrika S H Simonsson; Håkan Ekvall; Leo Flamholc; Vidar Ormaasen; Jan Vesterbacka; Eva Wallmark; Michael Ashton; Magnus Gisslén
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-10-02       Impact factor: 2.745

6.  Hierarchical Bayesian inference for HIV dynamic differential equation models incorporating multiple treatment factors.

Authors:  Yangxin Huang; Hulin Wu; Edward P Acosta
Journal:  Biom J       Date:  2010-08       Impact factor: 2.207

Review 7.  Modeling antiretroviral drug responses for HIV-1 infected patients using differential equation models.

Authors:  Yanni Xiao; Hongyu Miao; Sanyi Tang; Hulin Wu
Journal:  Adv Drug Deliv Rev       Date:  2013-04-17       Impact factor: 15.470

Review 8.  Facilitation of drug evaluation in children by population methods and modelling.

Authors:  Michel Tod; Vincent Jullien; Gérard Pons
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

9.  Statistical Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Systematic Review of Methodological Papers.

Authors:  Abualbishr Alshreef; Nicholas Latimer; Paul Tappenden; Ruth Wong; Dyfrig Hughes; James Fotheringham; Simon Dixon
Journal:  Med Decis Making       Date:  2019-10-24       Impact factor: 2.583

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.